02 Apr 2024

Notice of annual general meeting in Xbrane Biopharma AB

01 Apr 2024

Change of number of shares and votes in Xbrane

27 Mar 2024

XBRANE BIOPHARMA RELEASES ANNUAL AND SUSTAINABILITY REPORT FOR 2023

19 Mar 2024

Xbrane resolves on a directed issue of shares to guarantors in connection with the completed rights issue

14 Mar 2024

Xbrane announces the outcome of the rights issue

08 Mar 2024

Xbrane publish supplement to prospectus

04 Mar 2024

Xbrane has received additional subscription undertakings corresponding to approximately SEK 18.1 million in the Company’s rights issue

27 Feb 2024

Trading in unit rights and BTUs in Xbrane’s rights issue will commence on 29 February 2024

27 Feb 2024

Xbrane publishes prospectus in connection with the company’s partially guaranteed rights issue of approximately SEK 343 million

26 Feb 2024

Xbrane Biopharma releases Year-end Report 2023

22 Feb 2024

Announcement from Extra General Meeting in Xbrane Biopharma AB

21 Feb 2024

Invitation to presentation of Xbrane Biopharma’s Year-end report 2023 on February 26, 2024

05 Feb 2024

Xbrane sends shareholder letter in connection with the proposed rights issue

22 Jan 2024

Notice of Extra General Meeting in Xbrane Biopharma AB

22 Jan 2024

Xbrane announces a rights issue of units of approximately SEK 343 million